Gossamer Bio, Inc. Profile Avatar - Palmy Investing

Gossamer Bio, Inc.

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing…

Biotechnology
US, San Diego [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Gossamer Bio, Inc. has no acquisition track records yet.

M&A Deals · History

Gossamer Bio, Inc. has no acquisition track records yet.

End of GOSS's Analysis
CIK: 1728117 CUSIP: 38341P102 ISIN: US38341P1021 LEI: - UEI: -
Secondary Listings
GOSS has no secondary listings inside our databases.